MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
EOLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Evolus (EOLS) Ownership - Who owns Evolus?

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
495.49M
P/E Ratio
N/A
Total Cash
61.74M
Projected Growth
N/A
Total Debt
154.91M
Revenue
277.94M
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
0.95
Total Debt/Equity
N/A
Revenue/Share
4.36 USD as % of share price

Fundamentals

EOLS
Capitalization
495M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
61.7M
Total Cash/Share
0.95
Total Debt
155M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.36%
Revenue
278M
ROE
N/A
Book Value
-18.65M
P/B Ratio
116.28
Cash Flow
N/A
Earnings
-0.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
2.27
Current Revenue Per Employee
176109.14
Dividends Per Share - Security
N/A
EBITDA
-33.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.31
Revenue To Assets
-26.80
Shares Held By Institutions
800M
Shares Outstanding - Current
64.7M
Total Liabilities
247M
Total Volume MTD
N/A
Value
-1
Gain YTD
-30.616
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EOLS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For EOLS
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EOLS showed earnings on August 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a manufacturer of neurotoxins

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com